`03/1072015 18:21 FAX
`18732868800
`SAULEIN6
`Lj003/O08
`
`UNITED STATES DiSTRICT COURT
`DISTRICT OF NEW JERSEY
`
`JAZZ PHARMACEUTICALS, INC.,
`
`Civil Action No. 13-391 (ES)(JAD)
`
`Plaintiff,
`
`(Filed Electronically)
`
`V.
`
`AMNEAL PHARMACEUTICALS, LLC
`and PAR PHARMACEUTICAL, INC.,
`
`Defendants,
`
`JAZZ PHARMACEUTICALS, INC.,
`
`Civil Action No. 14-3235 (ES)(JAD)
`
`Plaintiff,
`
`V.
`
`AMNEAL PHARMACEUTICALS,
`LLC,
`
`Defendant.
`
`JAZZ PTJARMACEIJTICALS, INC. and
`JAZZ PHARMACEUTICALS
`IRELAND LIMITED,
`
`Plaintiffs,
`
`V.
`
`AMNEAL PHARMACEUTICALS,
`LLC,
`
`Defendant.
`
`Civil Action No. 15-1043 (ES)(JAD)
`
`
`
`Case 2:13-cv-00391-ES-JAD Document 123 Filed 03/18/15 Page 2 of 6 PageID: 1734
`03/IO/2O15 18:22 FAX
`18732888800
`SAULE WING
`Ia_i 004/008
`
`JAZZ PHARMACEUTICALS, INC.,
`
`Civil Action No. 14-5139 (ES)(JAD)
`
`Plaintiff,
`
`vi
`
`PAR PHARMACEUTICAL, INC.,
`
`Defendant
`
`JAZZ PHARMACEUTICALS, INC. and
`JAZZ PHARMACEUTICALS
`IRELAND LIMITED,
`
`Plaintiffs,
`
`V.
`
`PAR PHARMACEUTICAL INC.,
`
`Defendant.
`
`CIjvil Action No. 14-6150 (ES)(JAD)
`
`JAZZ PHARMACEUTICALS, INC.,
`
`Civil Action No. 15-173 (ES)(JAD)
`
`Plaintiff,
`
`V.
`
`PAR PHARMACEUTICAL, INC.,
`
`Defendani.
`
`
`
`Case 2:13-cv-00391-ES-JAD Document 123 Filed 03/18/15 Page 3 of 6 PageID: 1735
`
`03/10/2915 18:22 FAX
`
`18732888800
`
`SAULE WING
`
`Ii 005/008
`
`JAZZ PHARMACEUTICALS, INC.,
`
`Civil Action No. 14-4467 (ES)(JAD)
`
`Plaintiff,
`
`V.
`
`RANBAXY LABORATORIES
`LTMITED AND RANBAXY INC.,
`
`Defendants.
`
`JAZZ PHARMACEUTICALS, INC. and
`JAZZ PHARMACEUTICALS
`IRELAND LIMITED,
`
`Plaintiffs,
`
`V.
`
`RANBAXY LABORATORIES
`LIMITED AND RANBAXY INC.,
`
`Defendants.
`
`Civil Action No. 14-6151 (ES)(JAD)
`
`JAZZ PHARMACEUTICALS, INC.,
`
`Ciivil Action No. 15-187 (ES)(JAD)
`
`Plaintiff,
`
`V.
`
`RANBAXY LABORATORIES
`LIMITED AND RANBAXY INC.,
`
`Defendants.
`
`
`
`Case 2:13-cv-00391-ES-JAD Document 123 Filed 03/18/15 Page 4 of 6 PageID: 1736
`ll 008/008
`03110/2015 18:22 FAX
`18732898800
`SAULE WING
`
`Civil Action No. 14-7757 (ES)(JAD)
`
`JAZZ PHARMACEUTICALS, INC. and
`JAZZ PHARMACEUTICALS
`IRELAND LIMITED,
`
`Plaintiffs,
`
`v.
`
`WATSON LABORATORIES, INC.,
`
`Defendant.
`
`-
`
`ESCJIEDULING ORDER
`
`TI-US MATTER having conic before the Court for a status conference in the
`
`above-referenced Civil Actions on January 8, 2015; and the Court having carefully
`
`considered the parties’ joint letter dated January 30, 2015 (DI 115); and pursuant to the
`
`Court’s BCE Text Ordeçated February 26, 2015 (D.I. 118); and for good cause shown:
`
`IT IS on this VSiay ofç, 2015
`
`ORDERED THAT:
`
`The discovery schedule in this matter shall be as follows:
`
`Event
`
`Amneal, Ranbaxy, and Watson answers and
`counterclaims or other responsive pleading
`inC.A.Nos. 15-1043, 15-187, and 14-7757
`
`Jazz files reply to Amneal’s. Ranbaxy’s,
`Watson’s, and Par’s counterclaims or other
`responsive pleading in C.A, Nos. 15.1043,
`15-187, 14-7757, and 15-173
`
`16 conference
`
`Plaintiff serves its Disclosure of Asserted
`Claims pursuant to L. Pat, R. 3.6(b)
`
`Date
`
`March 23, 2015
`
`April 13, 2015
`
`April 20,2015 ot.4—
`
`April 27, 2015
`
`z3o
`
`
`
`Case 2:13-cv-00391-ES-JAD Document 123 Filed 03/18/15 Page 5 of 6 PageID: 1737
`O3/0/2O15 18:22 FAX
`18732886800
`SAULEWIN8
`Ij007/008
`¾
`
`— Event
`
`-.
`
`Defendants serve Invalidity Contentions
`and Non-Infringement Contentions pursuant
`to I,. Pat. R. 3.6(c)-(O
`
`The parties submit a proposed Discovery
`Confidentiality Order pursuant to L. Pat. R,
`2.2 for the Court’s consideration
`
`Plaintiff serves its Infringement Contentions
`and Responses to Invalidity Contentions on
`Defendants pursuant to L. Pat, R. 3.6(g)-(i)
`
`The parties exchange proposed terms for
`construction pursuant to L. Pat. it 4.1(a)
`
`The parties exchange preliminary proposed
`constructions and identification of intrinsic
`and extrinsic evidence pursuant to L. Pat. R.
`4.2(a)(b)
`
`The parties exchange evidence opposing
`proposed claim constructions pursuant to L
`Pat. R. 4.2(e), and shall thereafter meet and
`confer to narrow the issues
`
`Date
`
`May 18, 2015
`
`May 18,2015
`
`July 16, 2015
`
`July 30, 2015
`
`August 20, 2015
`
`September 3, 2015
`
`The parties file a 3oiridim Construction
`and Prehearing Statement pursuant to L.
`Pat. R. 4.3(a)-(e)
`
`I
`
`September 21,2015
`
`The parties complete fact discovery relating
`to claim construction pursuant to L. Pat. R.
`4,4
`
`The parties file and serve their opening
`Markman submissions pursuant to L1 Pat R1
`4.5(a)
`
`The parties complete expert discovery
`regarding Markinan issues pursuant to L.
`Pat. R. 4.5(b)
`
`October 1 9, 201 5
`
`November 5, 2015
`
`December 7, 2015 -
`
`Deadline for motions to amend pleadings or
`add parties
`
`August 24, 2015
`
`
`
`Case 2:13-cv-00391-ES-JAD Document 123 Filed 03/18/15 Page 6 of 6 PageID: 1738
`03/10/2015 18:22 FAX
`19732888800
`SAULEWING
`IJ008/008
`1
`
`Event
`
`The parties file and serve their responding
`Markman submissions pursuant to L. Pat. R.
`4.5(c)
`
`The parties propose a schedule to the Court
`for a CLaim Construction Hearing pursuant
`to L. Pat. R. 4.6
`
`Markinan Hearing
`
`Close of fact discovery
`
`Opening expert reports on issues for which
`the party bears the burden of proof
`
`Rebuttal expert reports
`
`Reply expert reports —
`
`Close of expert discovery
`
`Date
`
`December 21, 2015
`
`January 18, 2016
`
`-—
`
`At the Court’s convenience
`
`March II, 2016
`
`- 60 days after the close of fact
`discovery or the Court’s
`Markman opinion, whichever is
`later
`
`60 days after service of opening
`expert reports
`
`30 days after service of rebuttal
`expert reports
`
`60 days after service bheply
`expert reports
`
`:
`
`Final pretrial conference
`
`To be determined
`
`Trial
`
`To be determined
`
`9a4r
`
`Hon. Joseph A. Dickson, U.S.M.J.
`
`cc: Hon. Esther Salas, U.S.D.J.
`
`